The Preeclampsia Drugs Market boost up with a CAGR of 10% & projected USD 2.14 billion by 2030. It is divided into type, treatment, route of administration, distribution channel and end-user.

Peptide and Anticoagulant Drugs Market was USD 1.53 billion in 2021 and will reach USD 2.45 billion by 2029, registering a CAGR of 6.10% during the forecast period.

Anti-Dermatomycosis Skin Drugs Market was USD 16,240.00 million in 2022, is predicted to reach USD 21,368.45 million, and will grow at a CAGR of 3.49% by 2030

The Sarcoma Drugs Market spikes a 9.00% CAGR worth $2435.31 million by 2030. It's divided by type, drug therapy, drug type, end-users, and distribution channel.

The Anti-Coccidial Drugs Market boost up with a CAGR of 9.2% & projected USD 3,103.95 million by 2030. It is divided into type, animals, distribution channel and end-user.

Antiviral Drugs Market raise at a CAGR of 5.5% & expand USD 107,700.57 million by 2030. It is analyzed as indication, patient type, products, drug type, end user.

The Transdermal Drugs Market growth at a CAGR of 5% & expected USD 9.60 billion by 2029. It is analyzed as product type, indication, distribution channel and end-user.

Anti-Dermatomycosis Skin Drugs Market was USD 16,240.00 million in 2022, is predicted to reach USD 21,368.45 million, and will grow at a CAGR of 3.49% by 2030

Topical Non-Steroidal Anti-Inflammatory Drugs Market was USD 2,648.65 million in 2022 and will reach USD 3973.29 million, growing at a CAGR of 5.20% by 2030

Oral Nonsteroidal Anti-Inflammatory Drugs Market was valued at USD 20,697.05 million in 2022, and it would grow to USD 32,641.01 billion, growing at around 5.86% by 2030